TruScreen is pleased to announce that the supply and export of the TruScreen Ultra have commenced with initial shipments to Latin America (Mexico) and the Middle East (Jordan).
This shipment of the TruScreen Ultra device follows the recent announcement that the 2nd generation device had been successful in gaining CE certification, thereby opening up the European Union and other select markets including the Middle East and Latin America.
TruScreen Limited CEO, Martin Dillon said “we are very pleased to announce that supply of our new 2nd generation Ultra device has commenced with initial shipments going to Mexico and Jordan. We had already targeted Mexico as a significant market opportunity for Truscreen and it is pleasing to note that the company has now initiated a new sales channel into the Middle East with our first shipments to Jordan. Now that we have CE certification of the new device, we are focused on expediting the manufacture and further supply of our new Truscreen Ultra device into the markets as quickly as possible”
TruScreen is the only device in the world that is a CE certified, stand-alone real time primary screening tool for Cervical Cancer. TruScreen has successfully combined the use of both optical and electrical tissue differentiation to create a clinically acceptable level of performance in the primary screening of cervical cancer.